Detection of unsuspected metachronous second primary malignancy giving rise to supposed "non-iodine avid metastasis" in differentiated thyroid carcinoma

Clinical Nuclear Medicine

Volumn 32, Issue 8, 2007, Pages 655-658

  Basu, Sandip ^a,b   Nair, Narendra ^a   Shet, Tanuja ^b  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

^b TATA MEMORIAL HOSPITAL   (India)

Author keywords

FDG PET; Second primary; Thyroid carcinoma

Indexed keywords

IODINE 131; THYROXINE;

ADULT; ARTICLE; CASE REPORT; DRUG UPTAKE; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HISTOPATHOLOGY; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPERMETABOLISM; INTESTINE; KIDNEY; KIDNEY CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; NEPHRECTOMY; PAPILLARY CARCINOMA; PATIENT CARE; POSITRON EMISSION TOMOGRAPHY; THYROID CARCINOMA; THYROIDECTOMY; WHOLE BODY SCINTISCANNING;

AGED; CARCINOMA, PAPILLARY; FALSE NEGATIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INCIDENTAL FINDINGS; IODINE RADIOISOTOPES; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RADIOPHARMACEUTICALS; THYROID NEOPLASMS;

EID: 34547653785     PISSN: 03639762     EISSN: None     Source Type: Journal    
DOI: 10.1097/RLU.0b013e3180a1ac5c     Document Type: Article

References (8)

1. Wang W, Larson SM, Tuttle RM, et al. Resistance of [18F]- fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine. Thyroid. 2001;11:1169-1175.
2. Helal BO, Merlet P, Toubert ME, et al. Clinical impact of (18)F-FDG PET in thyroid carcinoma patients with elevated thyroglobulin levels and negative (131)I scanning results after therapy. J Nucl Med. 2001;42:1464-1469.
3. Lowe VJ, Mullan BP, Hay ID, et al. 18F-FDG PET of patients with Hurthle cell carcinoma. J Nucl Med. 2003;44:1402-1406.
4. Yeo JS, Chung JK, So Y, et al. F-18-fluorodeoxyglucose positron emission tomography as a presurgical evaluation modality for I-131 scan-negative thyroid carcinoma patients with local recurrence in cervical lymph nodes. Head Neck. 2001;23:94-103.
5. Liberale G, Van Laethem JL, Gay F, et al. The role of PET scan in the preoperative management of oesophageal cancer. Eur J Surg Oncol. 2004;30:942-947.
6. Woolson SL, Downey RJ, Meyers BF, et al. Results of the American College of Surgeons Oncology Group Z0050 trial: the utility of positron emission tomography in staging potentially operable non-small cell lung cancer. J Thorac Cardiovasc Surg. 2003;126:1943.
7. Ishimori T, Patel PV, Wahl RL. Detection of unexpected additional primary malignancies with PET/CT. J Nucl Med. 2005;46:752-757.
8. 131I whole-body scanning results? J Nucl Med. 2005;46:1164-1170.